Literature DB >> 7807484

Post-cesarean section febrile morbidity. Antibiotic prophylaxis in low-risk patients.

P Jakobi1, A Weissman, E Sigler, K Margolis, E Z Zimmer.   

Abstract

A study was conducted to assess whether antibiotic prophylaxis in low-risk patients for post-cesarean febrile morbidity was beneficial and cost effective. In a randomized, prospective study, 167 patients received a single, 1-g dose of cefazolin before clamping of the cord, and 140 did not. In the group given prophylaxis the febrile morbidity and postoperative therapeutic antibiotic usage were significantly lower than in the group not given prophylaxis (9% vs. 17.9%, P = .035, and 6.5% vs. 20%, P < .001, respectively). We conclude that single-dose cefazolin prophylaxis is both beneficial and cost effective, even in patients considered to be at low risk of post-cesarean febrile morbidity. Since the value of antibiotic prophylaxis in high-risk patients is accepted, universal antibiotic prophylaxis in every cesarean section case is suggested.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7807484

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

Review 1.  Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Authors:  Fiona M Smaill; Rosalie M Grivell
Journal:  Cochrane Database Syst Rev       Date:  2014-10-28

Review 2.  Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Authors:  Fiona M Smaill; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

3.  Postpartum endomyometritis.

Authors:  K L Williams; J G Pastorek Ii
Journal:  Infect Dis Obstet Gynecol       Date:  1995

4.  [Early maternal complications of cesarean section: about 460 cases in two university hospitals in Yaounde, Cameroon].

Authors:  Jean Dupont Kemfang Ngowa; Anny Ngassam; Jovanny Tsuala Fouogue; Junie Metogo; Alexis Medou; Jean Marie Kasia
Journal:  Pan Afr Med J       Date:  2015-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.